VIVUS Inc (NASDAQ:VVUS)

2.33
Delayed Data
As of Apr 27
 -0.13 / -5.28%
Today’s Change
2.28
Today|||52-Week Range
5.95
-19.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$255.5M

Company Description

VIVUS, Inc. is a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
351 East Evelyn Avenue
Mountain View California 94041
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Other institutional55.45%
Individual stakeholders25.64%
Mutual fund holders15.84%

Top Executives

Seth H. Z. FischerChief Executive Officer & Director
Guy P. MarshVice President-US Operations & General Manager
Svai S. SanfordChief Financial & Accounting Officer
Wesley W. DayVice President-Clinical Development
Santosh T. VargheseVice President-Medical & Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account